
Ebenezer O. Sackey
Examiner (ID: 17838)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1613, 1201, 1626, 1624, 1621 |
| Total Applications | 2086 |
| Issued Applications | 1598 |
| Pending Applications | 91 |
| Abandoned Applications | 399 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4960639
[patent_doc_number] => 20080275064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Substituted Pyrimidines as Adenosine Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/911187
[patent_app_country] => US
[patent_app_date] => 2006-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37229
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20080275064.pdf
[firstpage_image] =>[orig_patent_app_number] => 11911187
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/911187 | Substituted Pyrimidines as Adenosine Receptor Antagonists | Apr 10, 2006 | Abandoned |
Array
(
[id] => 5689020
[patent_doc_number] => 20060287335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Serotonergic agents for treating sexual dysfunction'
[patent_app_type] => utility
[patent_app_number] => 11/396307
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7793
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287335.pdf
[firstpage_image] =>[orig_patent_app_number] => 11396307
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/396307 | Serotonergic agents for treating sexual dysfunction | Mar 29, 2006 | Abandoned |
Array
(
[id] => 5876216
[patent_doc_number] => 20060167299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Hydrothermally synthesized Mo-V-M-Nb-X oxide catalysts for the selective oxidation of hydrocarbons'
[patent_app_type] => utility
[patent_app_number] => 11/389940
[patent_app_country] => US
[patent_app_date] => 2006-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16389
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20060167299.pdf
[firstpage_image] =>[orig_patent_app_number] => 11389940
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/389940 | Hydrothermally synthesized Mo-V-M-Nb-X oxide catalysts for the selective oxidation of hydrocarbons | Mar 26, 2006 | Issued |
Array
(
[id] => 178089
[patent_doc_number] => 07655798
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => 'Process of making crystalline Type II aripiprazole'
[patent_app_type] => utility
[patent_app_number] => 11/377398
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4245
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655798.pdf
[firstpage_image] =>[orig_patent_app_number] => 11377398
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/377398 | Process of making crystalline Type II aripiprazole | Mar 16, 2006 | Issued |
Array
(
[id] => 63074
[patent_doc_number] => 07763650
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-27
[patent_title] => 'Pharmaceutical compound and method'
[patent_app_type] => utility
[patent_app_number] => 11/375936
[patent_app_country] => US
[patent_app_date] => 2006-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4503
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/763/07763650.pdf
[firstpage_image] =>[orig_patent_app_number] => 11375936
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/375936 | Pharmaceutical compound and method | Mar 14, 2006 | Issued |
Array
(
[id] => 5609169
[patent_doc_number] => 20060270685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Anhydrous ziprasidone mesylate and a process for its preparation'
[patent_app_type] => utility
[patent_app_number] => 11/376551
[patent_app_country] => US
[patent_app_date] => 2006-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6990
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270685.pdf
[firstpage_image] =>[orig_patent_app_number] => 11376551
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/376551 | Anhydrous ziprasidone mesylate and a process for its preparation | Mar 13, 2006 | Abandoned |
Array
(
[id] => 5700754
[patent_doc_number] => 20060217439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Stable no-delivering compounds'
[patent_app_type] => utility
[patent_app_number] => 11/376756
[patent_app_country] => US
[patent_app_date] => 2006-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5769
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217439.pdf
[firstpage_image] =>[orig_patent_app_number] => 11376756
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/376756 | Stable no-delivering compounds | Mar 13, 2006 | Issued |
Array
(
[id] => 5677455
[patent_doc_number] => 20060182810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles'
[patent_app_type] => utility
[patent_app_number] => 11/365625
[patent_app_country] => US
[patent_app_date] => 2006-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9934
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20060182810.pdf
[firstpage_image] =>[orig_patent_app_number] => 11365625
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/365625 | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles | Mar 1, 2006 | Abandoned |
Array
(
[id] => 5410102
[patent_doc_number] => 20090124001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => '9-AMINO-ACRIDINE DERIVATIVES AND THEIR USE FOR ELIMINATING MISFOLDED PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 11/817622
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7341
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20090124001.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817622
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817622 | 9-amino-acridine derivatives and their use for eliminating misfolded proteins | Feb 27, 2006 | Issued |
Array
(
[id] => 5632417
[patent_doc_number] => 20060148887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Chemical compounds'
[patent_app_type] => utility
[patent_app_number] => 11/358601
[patent_app_country] => US
[patent_app_date] => 2006-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7108
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148887.pdf
[firstpage_image] =>[orig_patent_app_number] => 11358601
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/358601 | Chemical compounds | Feb 20, 2006 | Abandoned |
Array
(
[id] => 803336
[patent_doc_number] => 07423040
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-09
[patent_title] => 'Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same'
[patent_app_type] => utility
[patent_app_number] => 11/354652
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 9696
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/423/07423040.pdf
[firstpage_image] =>[orig_patent_app_number] => 11354652
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/354652 | Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same | Feb 15, 2006 | Issued |
Array
(
[id] => 5609168
[patent_doc_number] => 20060270684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Crystalline forms of ziprasidone mesylate'
[patent_app_type] => utility
[patent_app_number] => 11/353421
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 13418
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270684.pdf
[firstpage_image] =>[orig_patent_app_number] => 11353421
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/353421 | Crystalline forms of ziprasidone mesylate | Feb 12, 2006 | Abandoned |
Array
(
[id] => 4779679
[patent_doc_number] => 20080287677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Salts of Aripiprazole'
[patent_app_type] => utility
[patent_app_number] => 11/883125
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5669
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287677.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883125
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883125 | Salts of aripiprazole | Jan 26, 2006 | Issued |
Array
(
[id] => 4629596
[patent_doc_number] => 08008490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Polymorphic forms of aripiprazole and method'
[patent_app_type] => utility
[patent_app_number] => 11/795909
[patent_app_country] => US
[patent_app_date] => 2006-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6817
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/008/08008490.pdf
[firstpage_image] =>[orig_patent_app_number] => 11795909
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/795909 | Polymorphic forms of aripiprazole and method | Jan 26, 2006 | Issued |
Array
(
[id] => 4634518
[patent_doc_number] => 08012969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-06
[patent_title] => '11C-labeled benzyl-lactam compounds and their use as imaging agents'
[patent_app_type] => utility
[patent_app_number] => 11/813779
[patent_app_country] => US
[patent_app_date] => 2006-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7403
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/012/08012969.pdf
[firstpage_image] =>[orig_patent_app_number] => 11813779
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813779 | 11C-labeled benzyl-lactam compounds and their use as imaging agents | Jan 10, 2006 | Issued |
Array
(
[id] => 4989621
[patent_doc_number] => 20070155962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Process for preparing titanyl phthalocyanine'
[patent_app_type] => utility
[patent_app_number] => 11/322077
[patent_app_country] => US
[patent_app_date] => 2005-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6298
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155962.pdf
[firstpage_image] =>[orig_patent_app_number] => 11322077
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/322077 | Process for preparing titanyl phthalocyanine | Dec 29, 2005 | Abandoned |
Array
(
[id] => 32929
[patent_doc_number] => 07790761
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-07
[patent_title] => 'Blockade of voltage dependent sodium channels'
[patent_app_type] => utility
[patent_app_number] => 11/312569
[patent_app_country] => US
[patent_app_date] => 2005-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23299
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/790/07790761.pdf
[firstpage_image] =>[orig_patent_app_number] => 11312569
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/312569 | Blockade of voltage dependent sodium channels | Dec 20, 2005 | Issued |
Array
(
[id] => 5285485
[patent_doc_number] => 20090099160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => '4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/793254
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31513
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099160.pdf
[firstpage_image] =>[orig_patent_app_number] => 11793254
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793254 | 4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors | Dec 14, 2005 | Abandoned |
Array
(
[id] => 5777580
[patent_doc_number] => 20060106220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Compositions and therapeutic methods involving isoflavones and analogues thereof'
[patent_app_type] => utility
[patent_app_number] => 11/300976
[patent_app_country] => US
[patent_app_date] => 2005-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5562
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20060106220.pdf
[firstpage_image] =>[orig_patent_app_number] => 11300976
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/300976 | Compositions and therapeutic methods involving isoflavones and analogues thereof | Dec 13, 2005 | Abandoned |
Array
(
[id] => 917350
[patent_doc_number] => 07323484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-29
[patent_title] => 'Farnesyl transferase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/287996
[patent_app_country] => US
[patent_app_date] => 2005-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14376
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/323/07323484.pdf
[firstpage_image] =>[orig_patent_app_number] => 11287996
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/287996 | Farnesyl transferase inhibitors | Nov 27, 2005 | Issued |